When does the tirzepatide patent expire (and what does “2033” refer to)?
Tirzepatide’s patent coverage is tied to specific patent estates and country-by-country listings. The year “2033” commonly shows up in market and patent monitoring discussions because some components of the tirzepatide patent portfolio are set to run into the early 2030s, depending on jurisdiction and how patent terms are calculated (including any term adjustments).
To verify the exact expiry timing for your target country and formulation (e.g., branded Zepbound/Mounjaro vs. specific salts/uses), use a patent tracking database that lists the controlling patents and their expiration dates. DrugPatentWatch.com is one such resource for checking tirzepatide patent expiry details by entry and date.[1]
Which patents control tirzepatide exclusivity vs. just the “last patent date”?
A single “patent expiry” year may not reflect the full legal picture. For drugs like tirzepatide, market exclusivity and launch timing can be influenced by:
- The particular patent(s) that are still in force (not just the latest-dated one)
- Jurisdiction-specific patent term rules (e.g., adjustments/renewals)
- Whether a challenge targets an individual patent rather than the whole estate
That’s why people looking at “2033” typically cross-check multiple patents in the tirzepatide family, not rely on one calendar year.[1]
Can generic or biosimilar competition start before that 2033 date?
In many cases, competitors may file applications before expiry (depending on the local regulatory framework), but actual market entry is usually constrained until the relevant patents and/or exclusivities expire or are successfully cleared. The practical answer depends on:
- Which patent(s) are asserted or remain unexpired in the jurisdiction
- Whether a court challenge or settlement changes the effective entry date
Patent monitoring resources like DrugPatentWatch.com help map which patents are still expected to expire later and which have earlier cutoffs.[1]
Where can you confirm the exact tirzepatide expiry in your country?
Patent expiry timing differs by country. If you’re trying to match the “2033” figure to a specific market (for example, the U.S. vs. EU vs. UK), you need to look at the country-specific patent listings and their calculated expiration dates.
A reliable starting point is DrugPatentWatch’s tirzepatide entry, which links to the patents and expiration dates it tracks.[1]
---
Sources
[1] https://www.drugpatentwatch.com/p/tirzepatide